Cite

HARVARD Citation

    Manji, J. et al. (n.d.). Safety of long‐term intranasal budesonide delivered via the mucosal atomization device for chronic rhinosinusitis. International forum of allergy & rhinology. 7 (5), pp. 488-493. [Online]. 
  
Back to record